Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Appointment of Joint Broker

16th Feb 2026 07:00

RNS Number : 0429T
Optima Health PLC
16 February 2026
 

16 February 2026

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

Appointment of Joint Broker

Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, announces the appointment of Cavendish Capital Markets Limited ("Cavendish") as joint broker to the Company with immediate effect.

Cavendish will work alongside Panmure Liberum, the Group's existing nominated adviser and corporate broker.

 

Enquiries

Optima Health

Jonathan Thomas, CEO

Heidi Giles, CFO

 

+44(0)3300085113

[email protected]

Panmure Liberum Limited

Nominated Adviser and Corporate Broker

Emma Earl / Will Goode/ Mark Rogers

Rupert Dearden

 

+44 (0)20 3100 2000

 

Cavendish Capital Markets

Joint Broker

Geoff Nash/Ben Jeynes/George Lawson

Julian Morse/Michael Johnson/Nigel Birks

 

+ 44 (0)20 7220 0500

ICR Healthcare

UK Financial PR Adviser

Mary-Jane Elliott / Angela Gray / Lindsey Neville

[email protected]

 

 

About Optima Health

Optima Health is the UK's leading provider of occupational health and wellbeing services, delivering clinically led, technology-driven solutions to organisations across the public and private sectors. With a team of more than 1,600 including 800 clinicians, Optima Health supports millions of employees and operates from a network of more than 50 clinics nationwide.

 In addition to its core UK market, Optima Health also operates in Ireland under Optima Health Ireland, providing occupational health services to clients nationwide.

 

For more information visit www.optimahealth.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPFLFVDFRIELIR

Related Shares:

Optima Health
FTSE 100 Latest
Value10,910.55
Change63.85